AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Bure Equity M&A Activity 2011

Jul 4, 2011

2899_rns_2011-07-04_ac6abca9-d91c-40ba-8313-0768a90285dc.pdf

M&A Activity

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

PRESS RELEASE Stockholm, 4 july 2011

THE PORTFOLIO COMPANY CMA MICRODIALYSIS RESTRUCTURES OPERATIONS

Bure Equity's portfolio company CMA Microdialysis sells its preclinical business and its subsidiary Dilab. CMA Microdialysis continuing operations will be renamed to Dipolyn Medical AB.

For more information see enclosed press releases and Dipylon Medicals web page:

www.dipylonmedical.com

For more information contact:

Patrik Tigerschiöld, CEO Tel. +46 8 614 00 20

Bure Equity AB (publ)

AI assistant

Bure Equity — M&A Activity 2011

2899_rns_2011-07-04_ac6abca9-d91c-40ba-8313-0768a90285dc.pdf

THE PORTFOLIO COMPANY CMA MICRODIALYSIS RESTRUCTURES OPERATIONS

For more information contact:

More from Bure Equity

Bure Equity M&A Activity 2011